Instrument number PB 102 of 2008
Amendment special arrangements under subsection 100(1) of the National Health Act 1953
I, DIANA MACDONELL, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under subsection 100(1) of the National Health Act 1953.
Dated 2nd OCTOBER 2008
DIANA MACDONELL
Acting Assistant Secretary
Pharmaceutical Evaluation Branch
Department of Health and Ageing
Amendment Special Arrangements — Chemotherapy Pharmaceuticals Access Program
1 Commencement
This instrument commences on 1 November 2008.
2 Amendment of PB 82 of 2008
Schedule 1 amends PB 82 of 2008.
Schedule 1 Amendments
[1] Schedule 2, item dealing with Epirubicin
omit from the columns in the order indicated:
| Powder for injection containing epirubicin hydrochloride 50 mg | Injection/intravesical | 4 | . . | Hospira Pty Limited |
[2] Schedule 2, item dealing with Irinotecan in the form I.V. injection
containing irinotecan hydrochloride trihydrate 100 mg in 5 mL
in the column headed “Brand” insert in alphabetical order:
Irinotecan-GA